Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;12(11):1367-76.
doi: 10.1517/14728222.12.11.1367.

Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia

Edward D Huey  1 , Nicole Armstrong, Parastoo Momeni, Jordan Grafman
Affiliations
Review

Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia

Edward D Huey et al. Expert Opin Ther Targets. 2008 Nov.

Abstract

Background: Frontotemporal dementia spectrum disorders are a set of neurodegenerative disorders affecting the frontal and anterior temporal lobes. They are often fatal, and currently no medications have been shown to slow their progression. Recent developments in understanding these disorders may aid in developing treatments.

Objective: To discuss the development of drug therapies for frontotemporal dementia spectrum disorders, both those under current investigation and those that could be targets for future investigation.

Methods: This review is divided into four sections: First, a brief review of frontotemporal dementia spectrum disorders; second, a discussion of the challenges in the development of drug therapies third, a review of the current clinical trials; and finally a discussion of some recent discoveries, which have sparked new areas of investigation.

Conclusions: Hopefully, advances in understanding of frontotemporal dementia spectrum disorders and clinical trial design will aid the development of new treatments.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors declare no conflicts of interest and have received no payment for the production of this manuscript.

Figures

Figure 1
Figure 1
Brain areas typically affected in frontotemporal dementia (prefrontal cortex and anterior temporal lobes).
See this image and copyright information in PMC

References

    1. Lund/Manchester. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57:416–8. - PMC - PubMed
    1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54. - PubMed
    1. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803–9. - PubMed
    1. Le Ber I, Guedj E, Gabelle A, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain. 2006;129:3051–65. - PubMed
    1. Knibb JA, Hodges JR. Semantic dementia and primary progressive aphasia: a problem of categorization? Alzheimer Dis Assoc Disord. 2005;(19 Suppl 1):S7–14. - PubMed

Publication types